OBJECTIVE: The purpose of this study was to determine whether the combined distribution of a panel of cellular messenger RNA markers can detect preeclampsia long before onset. STUDY DESIGN: We compared blood at 10-14 weeks from 11 women who ultimately experienced preeclampsia with 88 matched control subjects. After multiples of the median conversion of all the markers, logistic regression was used to calculate the risk of the development of preeclampsia. RESULTS: Higher multiples of the median values than expected were found for endoglin, fms-related tyrosine kinase 1, and transforming growth factor-β1. Lower multiples of the median values were found for placental growth factor and placental protein 13. Endoglin fms-related tyrosine kinase 1 and transforming growth factor-β1 had the best discriminant power. Messenger RNA species provided independent contributions to the prediction of preeclampsia. In fact, 11 women with preeclampsia scored a median risk of 50% of experiencing preeclampsia. Control subjects scored a median risk of preeclampsia of 0.18%. The detection rate at a 5% false positive rate was 72.3%. CONCLUSION: The messenger RNA dosage in maternal blood would be a useful method for the calculation of the risk of the development of preeclampsia.

Farina A, Zucchini C, Sekizawa A, Purwosunu Y, Sanctis PD, Santarsiero G, et al. (2010). Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 203, 575-575.e7 [10.1016/j.ajog.2010.07.043].

Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks.

FARINA, ANTONIO;ZUCCHINI, CINZIA;RIZZO, NICOLA;MORANO, DANILA;
2010

Abstract

OBJECTIVE: The purpose of this study was to determine whether the combined distribution of a panel of cellular messenger RNA markers can detect preeclampsia long before onset. STUDY DESIGN: We compared blood at 10-14 weeks from 11 women who ultimately experienced preeclampsia with 88 matched control subjects. After multiples of the median conversion of all the markers, logistic regression was used to calculate the risk of the development of preeclampsia. RESULTS: Higher multiples of the median values than expected were found for endoglin, fms-related tyrosine kinase 1, and transforming growth factor-β1. Lower multiples of the median values were found for placental growth factor and placental protein 13. Endoglin fms-related tyrosine kinase 1 and transforming growth factor-β1 had the best discriminant power. Messenger RNA species provided independent contributions to the prediction of preeclampsia. In fact, 11 women with preeclampsia scored a median risk of 50% of experiencing preeclampsia. Control subjects scored a median risk of preeclampsia of 0.18%. The detection rate at a 5% false positive rate was 72.3%. CONCLUSION: The messenger RNA dosage in maternal blood would be a useful method for the calculation of the risk of the development of preeclampsia.
2010
Farina A, Zucchini C, Sekizawa A, Purwosunu Y, Sanctis PD, Santarsiero G, et al. (2010). Performance of messenger RNAs circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 203, 575-575.e7 [10.1016/j.ajog.2010.07.043].
Farina A; Zucchini C; Sekizawa A; Purwosunu Y; Sanctis PD; Santarsiero G; Rizzo N; Morano D; Okai T.
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/92256
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 20
  • Scopus 53
  • ???jsp.display-item.citation.isi??? 46
social impact